We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antioxidants Treat Smith-Lemli-Opitz Syndrome

News   Feb 05, 2018 | By Ellen Goldbaum for University at Buffalo

 
Evidenced-Based Antioxidant Therapy Prevents Vision Loss Caused by Smith-Lemli-Opitz Syndrome

Light microscopy images of retinas from animal model of Smith-Lemli-Opitz Syndrome (SLOS). Treatment with antioxidant combination therapy (right) preserved normal retinal structure and prevented degeneration and death of photoreceptor cells (rods and cones). Credit: Steven Fliesler

 
 
 

RELATED ARTICLES

Fat Fuels Aggressive Brain Cancers

News

Fat is powering tumour growth in brain cancer, finds a new study by Cardiff University and the University of Florida.

READ MORE

Glioblastoma Overcomes Treatment Resistance in Promising Preclinical Study

News

A novel method of overcoming treatment resistance to both PD-1 and adoptive cellular therapy has been identified, by employing a concomitant hematopoietic stem and progenitor cell transfer.

READ MORE

Workers Who Commute Through Nature Report Better Mental Health

News

People who commute through natural environments report better mental health, research based on questionnaires answered by nearly 3,600 participants from four European cities has concluded.


READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE